FDA Inspection
Merck Serono SA (Vevey)Merck Serono SA (Vevey) – FDA Inspection, Jun 9, 2011
Record Details
This FDA Inspection record concerns Merck Serono SA (Vevey), with an inspection on June 9, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Merck Serono SA (Vevey)
- Inspection Date
- June 9, 2011
- Product Type
- Drugs
View Company Profile
ID · 94560388-a1bb-4c0e-96eb-e4d514dddaf3
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 732618
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Merck Serono SA (Vevey)
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 6, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 30, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 15, 2016 | Not classified | Office of Inspections and Investigations | |
| February 5, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Merck Serono SA (Vevey)
- FDA Inspection 1204345 - 2023-04-06
- FDA Inspection 1053823 - 2018-04-30
- FDA Inspection 995521 - 2016-11-15
- FDA Inspection 964102 - 2016-02-05
- FDA Inspection 811116 - 2012-11-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.